Order Article Reprints

Mendoza-Rodríguez MG, Sánchez-Barrera CÁ, Callejas BE, García-Castillo V, Beristain-Terrazas DL, Delgado-Buenrostro NL, Chirino YI, León-Cabrera SA, Rodríguez-Sosa M, Gutierrez-Cirlos EB, et al. Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis. International Journal of Molecular Sciences. 2020; 21(6):2130. https://doi.org/10.3390/ijms21062130

Mendoza-Rodríguez, Mónica G., C. Ángel Sánchez-Barrera, Blanca E. Callejas, Verónica García-Castillo, Diana L. Beristain-Terrazas, Norma L. Delgado-Buenrostro, Yolanda I. Chirino, Sonia A. León-Cabrera, Miriam Rodríguez-Sosa, Emma Bertha Gutierrez-Cirlos, and et al. 2020. "Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis" International Journal of Molecular Sciences 21, no. 6: 2130. https://doi.org/10.3390/ijms21062130

Mendoza-Rodríguez, M. G., Sánchez-Barrera, C. Á., Callejas, B. E., García-Castillo, V., Beristain-Terrazas, D. L., Delgado-Buenrostro, N. L., Chirino, Y. I., León-Cabrera, S. A., Rodríguez-Sosa, M., Gutierrez-Cirlos, E. B., Pérez-Plasencia, C., Vaca-Paniagua, F., Meraz-Ríos, M. A., & Terrazas, L. I. (2020). Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis. International Journal of Molecular Sciences, 21(6), 2130. https://doi.org/10.3390/ijms21062130